Joeri Aerts
Joeri Aerts
Onbekend partnerschap
Geverifieerd e-mailadres voor
Geciteerd door
Geciteerd door
Standardization and quality control studies of ‘real-time’quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection…
J Gabert, E Beillard, VHJ Van der Velden, W Bi, D Grimwade, ...
Leukemia 17 (12), 2318-2357, 2003
Selection of appropriate control genes to assess expression of tumor antigens using real-time RT-PCR
JL Aerts, MI Gonzales, SL Topalian
Biotechniques 36 (1), 84-91, 2004
Current approaches in dendritic cell generation and future implications for cancer immunotherapy
S Tuyaerts, JL Aerts, J Corthals, B Neyns, C Heirman, K Breckpot, ...
Cancer Immunology, Immunotherapy 56 (10), 1513-1537, 2007
CD83 expression on dendritic cells and T cells: correlation with effective immune responses
C Aerts‐Toegaert, C Heirman, S Tuyaerts, J Corthals, JL Aerts, A Bonehill, ...
European journal of immunology 37 (3), 686-695, 2007
Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression
G Lize, JL Aerts, MI Gonzales, N Chinnasamy, RA Morgan, SL Topalian
Human gene therapy 14 (6), 497-507, 2003
Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics
K Breckpot, JL Aerts, K Thielemans
Gene therapy 14 (11), 847-862, 2007
A real-time quantitative reverse transcriptase polymerase chain reaction (RT–PCR) to detect breast carcinoma cells in peripheral blood
J Aerts, W Wynendaele, R Paridaens, MR Christiaens, ...
Annals of oncology 12 (1), 39-46, 2001
Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors
M Dullaers, S Van Meirvenne, C Heirman, L Straetman, A Bonehill, ...
Gene therapy 13 (7), 630-640, 2006
Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4+ CD25+ regulatory T cells
S Tuyaerts, S Van Meirvenne, A Bonehill, C Heirman, J Corthals, ...
Journal of leukocyte biology 82 (1), 93-105, 2007
The interferon inducer ampligen [poly (I)-poly (C12U)] markedly protects mice against coxsackie B3 virus-induced myocarditis
E Padalko, D Nuyens, A De Palma, E Verbeken, JL Aerts, E De Clercq, ...
Antimicrobial agents and chemotherapy 48 (1), 267-274, 2004
Monitorial citizens or civic omnivores? Repertoires of civic participation among university students
L Hustinx, LCPM Meijs, F Handy, RA Cnaan
Youth & Society 44 (1), 95-117, 2012
A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption
SD Allard, B De Keersmaecker, AL de Goede, EJ Verschuren, J Koetsveld, ...
Clinical immunology 142 (3), 252-268, 2012
Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer
SK Baird, JL Aerts, A Eddaoudi, M Lockley, NR Lemoine, IA McNeish
Oncogene 27 (22), 3081-3090, 2008
Attenuated expression of A20 markedly increases the efficacy of double-stranded RNA-activated dendritic cells as an anti-cancer vaccine
K Breckpot, C Aerts-Toegaert, C Heirman, U Peeters, R Beyaert, JL Aerts, ...
The Journal of Immunology 182 (2), 860-870, 2009
Enhanced suppressive capacity of tumor‐infiltrating myeloid‐derived suppressor cells compared with their peripheral counterparts
SK Maenhout, S Van Lint, PU Emeagi, K Thielemans, JL Aerts
International journal of cancer 134 (5), 1077-1090, 2014
Proinflammatory characteristics of SMAC/DIABLO-induced cell death in antitumor therapy
PU Emeagi, S Van Lint, C Goyvaerts, S Maenhout, A Cauwels, ...
Cancer research 72 (6), 1342-1352, 2012
Location, location, location: functional and phenotypic heterogeneity between tumor-infiltrating and non-infiltrating myeloid-derived suppressor cells
SK Maenhout, K Thielemans, JL Aerts
Oncoimmunology 3 (10), e956579, 2014
Induction of antigen-specific CD8+ cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA
A Michiels, K Breckpot, J Corthals, S Tuyaerts, A Bonehill, C Heirman, ...
Gene therapy 13 (13), 1027-1036, 2006
Modulation of regulatory T cell function by monocyte-derived dendritic cells matured through electroporation with mRNA encoding CD40 ligand, constitutively active TLR4, and CD70
JJ Pen, B De Keersmaecker, SK Maenhout, AMT Van Nuffel, C Heirman, ...
The Journal of Immunology 191 (4), 1976-1983, 2013
The combination of 4‐1BBL and CD40L strongly enhances the capacity of dendritic cells to stimulate HIV‐specific T cell responses
B De Keersmaecker, C Heirman, J Corthals, C Empsen, LA van Grunsven, ...
Journal of leukocyte biology 89 (6), 989-999, 2011
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20